Pattern of Pseudomonas aeruginosa drug resistance in Tabriz Children Hospital

Z Ghorashi1, N Nezami, R Ghotaslou

  • 1Department of Pediatrics, Tabriz Children Hospital, Tabriz University (Medical Sciences), Tabriz, Eastern Azerbaijan, Iran.

Insights

Pseudomonas aeruginosa exhibits high drug resistance, particularly in young children requiring medical intervention. Ciprofloxacin remains relatively effective, but increasing resistance necessitates updated antibiotic susceptibility testing for Pseudomonas infections.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Pediatric Medicine

Background:

  • Increasing reports of drug resistance in Pseudomonas aeruginosa infections.
  • Pseudomonas aeruginosa is a significant opportunistic pathogen, especially in healthcare settings.

Purpose of the Study:

  • To investigate the drug resistance patterns of Pseudomonas aeruginosa in a pediatric population.
  • To identify effective antibiotics for treating Pseudomonas infections in children.

Main Methods:

  • Cross-sectional study analyzing 84 positive Pseudomonas cultures over 3 years.
  • Data collected from patient records at Tabriz Pediatric Medical Center.
  • Statistical analysis of patient demographics and antibiotic resistance patterns.

Main Results:

  • 81.9% of patients were under 2 years old, often with prior medical interventions.
  • Positive cultures predominantly from bronchial and eye discharges, with 81% from intensive care and neonatal units.
  • High resistance (>95%) to Ampicillin, Ceftizoxime, Cotrimoxasol, and Cefotoxime.
  • 50% resistance to Ceftazidime; lowest resistance observed with Ciprofloxacin.

Conclusions:

  • Ciprofloxacin is currently a relatively effective antibiotic for Pseudomonas infections in this pediatric cohort.
  • The increasing resistance to Ciprofloxacin and its limited use in children highlight the need for updated antibiotic susceptibility testing.
  • Regular review and updating of antibiotic discs used in antibiograms are crucial for effective treatment strategies.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...